TABLE OF CONTENTS

A. EXECUTIVE SUMMARY
B. MARKET DATA
C. HIGH-IMPACT STORIES (7)
D. MODERATE-IMPACT STORIES (6)
E. ECONOMY WATCH (5)
F. EARNINGS WATCH (3)
G. WHAT’S NEXT
H. CHART OF THE DAY

A. EXECUTIVE SUMMARY -> TOP

B. MARKET DATA -> TOP

A Treasury debt-buyback expansion eased bond-market pressure, driving yields and the VIX lower together and lifting the S&P 500 (+0.21%), Dow (+0.22%) and NYSE Composite (+0.32%); a 5.6% plunge in the PHLX Semiconductor Index dragged the Nasdaq 100 (-0.22%). Breadth was broad outside chips — Russell 2000 (+0.50%) and Healthcare (+3.37%, Merck +12.6% on a melanoma-vaccine trial win with Moderna) led, while Technology (-0.69%) and Industrials (-1.19%) lagged on the semiconductor rout (Dell -6.6%, Lam Research -6.3%, Broadcom -4.6%). Gold surged 3.6% to $4,580/oz as the dollar fell 0.86%, while Bitcoin’s 6.25% gain traced to a separate SEC crypto-regulation proposal, decoupled from the equity/bond rally. VIX fell 6% alongside the yield decline, confirming bonds are endorsing rather than resisting the risk-on move.

CLOSING PRICES – Wednesday, August 19, 2026:

MAJOR INDICES

NYSE breadth (+0.32%) and the Dow (+0.22%) confirmed a broad advance, while the Nasdaq 100’s -0.22% shows the pullback was concentrated in chips, not a market-wide risk-off. DJ Transportation (-0.16%) and the Dow (+0.22%) sit inside a 0.4-point spread — no meaningful Dow Theory divergence today. Russell 2000’s 0.50% gain marks a modest small-cap outperformance versus the S&P’s 0.21%, consistent with the lower-yield, weaker-dollar backdrop rather than a broad breadth confirmation.

VOLATILITY & TREASURIES

VIX fell 6% as the Treasury’s expanded buyback program eased term-premium concerns, pulling the 10Y down 6.8bps and the 2Y down 1.1bps — a bull-flattening move signaling reduced bond-supply fear, not growth risk (the inverse of a VIX-up/yields-up inflation-fear signature). DXY’s 0.86% slide tracked the yield decline rather than a safe-haven bid, and the joint equity-bond rally confirms the bond market is endorsing, not resisting, the risk-on tone.

COMMODITIES

Gold, silver and platinum surged together (+3.6% to +5.4%) on the weaker dollar and lower yields — precious metals moving in lockstep, not splitting, signals a rate/dollar-driven move rather than a differentiated safe-haven or industrial-demand story. Copper’s flat 0.22% confirms this wasn’t a growth/industrial signal. Bitcoin’s 6.25% gain decoupled entirely from the metals rally, tracing instead to a fresh SEC crypto-regulation proposal — a crypto-specific catalyst, not a risk proxy.

ENERGY

WTI and Brent both sat out the rally entirely (+0.25% and +0.48%), confirming the day’s dominant driver was a bond/dollar story, not a commodity-wide move — oil moving with equities but by a negligible amount is a non-signal rather than a demand read. Henry Hub was similarly flat. Dutch TTF’s 0.89% gain was a pure EUR/USD pass-through (the underlying €/MWh price was unchanged) rather than any European-gas-specific development, so there is no US-Europe energy divergence to report today.

S&P 500 SECTORS

Healthcare (+3.37% 1D) led on Merck’s vaccine-trial win and is also the year’s strongest sector (+28.61% 12M) — a session catalyst reinforcing an existing trend. Basic Materials (+3.62% 1D) rode the gold/silver rally, extending a strong month (+10.77%) and year (+37.47%). Technology (-0.69%) and Industrials (-1.19%) were the day’s laggards on the semiconductor selloff, though both remain solidly positive over 12 months.

TOP MEGA-CAP MOVERS:

GAINERS

DECLINERS

C. HIGH-IMPACT STORIES -> TOP

1. Treasury Doubles Its Long-Bond Buybacks and the 30-Year Breaks From a 19-Year High — the Day’s Rates Catalyst Was Fiscal, Not Monetary

The core facts:The Treasury announced today that it will at least double the maximum size of its liquidity-support buyback operations in nominal long-dated coupons, from $2 billion to at least $4 billion per operation, covering both the 10-to-20-year and 20-to-30-year sectors. The larger operations run from September 9 through November 4. The reaction was immediate and one-directional: the 10-year yield fell 6.8 bps to 4.638%, the 2-year fell only 1.1 bps to 4.164%, and the 30-year gave up roughly 9 bps to about 5.19% — one session after it had set a 19-year high near 5.33%. The dollar index fell 0.86% to 98.80 and the VIX fell 6.00% to 14.89. The S&P 500 closed +0.21% at 7,707.98, the Dow +0.22% and the NYSE Composite +0.32%.

Why it matters:The shape of the move is the information. A 6.8 bp fall at the 10-year against a 1.1 bp fall at the 2-year is a bull flattener driven almost entirely by term premium — the market repricing the cost of absorbing long-dated supply, not repricing the path of policy. That distinction matters because it means today’s rally in bonds carries no dovish signal about the Fed whatsoever, which is precisely why it could coexist with a hawkish FOMC document released the same afternoon. Equally telling is what fell alongside yields: a weaker dollar and a lower VIX in the same session as a bond rally is the signature of supply relief, the mirror image of the growth-scare pattern where bonds rally as equities and the dollar catch a haven bid. Treasury has effectively confirmed it will lean against disorderly long-end pricing with total public debt approaching $40 trillion — a backstop equities can lean on, and one that arrived with the 30-year at levels last seen in 2007.

What to watch:The first enlarged operation on September 9 — whether actual purchase sizes reach the $4 billion ceiling, and whether the 30-year holds below 5.20% into it. A return above 5.33% would signal the announcement bought duration relief rather than a durable floor.

2. Trump Pauses the First-Ever Section 338 Tariffs on Canada Roughly Two Hours Before They Attached — and Nothing Was Published to Effect It

The core facts:Late Tuesday evening, hours before 50% duties on roughly $20 billion of Canadian imports were set to attach at 12:01 a.m. ET Wednesday, Trump announced a three-day pause, citing a deal subject to the finalization of documents. The duties now attach at 12:01 a.m. ET Saturday, August 22. They were imposed under three proclamations signed July 20 invoking Section 338 of the Tariff Act of 1930 — the first use of that provision by any US president — targeting autos, alcoholic beverages and dairy. USTR said the agreement would include broader market access for American goods and economic security commitments; no terms were released. Prime Minister Carney said substantial progress had been made “although important work still remains.” USD/CAD fell to roughly 1.3810, down 0.62%.

Why it matters:The pause exists as a social-media post and nothing more. No presidential document, notice or rule suspending or amending the Section 338 actions was published in the Federal Register, and no USTR, BIS or OFAC document was published at all for the date — so importers face a legal position in which the proclamations remain operative on their face and the relief is verbal. That is a live compliance exposure, not a technicality: the proclamation annexes reach hundreds of tariff lines well beyond the three headline sectors, a valid USMCA certificate of origin does not exempt covered goods, and there is no published in-transit exception, so liability turns on date of entry for consumption. Two further unknowns carry real money. Reported terms halving Section 232 steel and aluminium duties from 50% to 25% rest on a single outlet and no government document; and no source states whether Canada’s own retaliatory tariffs on steel, aluminium and autos come off, even though their removal was made a US precondition on August 14. A three-day extension is the shortest possible reprieve, which is itself a signal about how much remains unsigned.

What to watch:The Federal Register and CBP CSMS guidance before Saturday’s 12:01 a.m. ET deadline — a published document is the only thing that converts the pause from rhetoric into an enforceable position for importers clearing goods this week.

3. The July Minutes Show Several Participants Ready to Hike and Nobody Arguing for a Cut — and the Market Did Not Reprice at All

The core facts:The minutes of the July 28-29 FOMC meeting were released at 14:00 ET. Section E carries the policy detail; what belongs here is the distribution and the market’s response to it. Several participants were prepared to raise rates at the meeting itself, and many said a hike would be needed if inflation does not decline toward 2%. No participant argued for easing — the entire distribution ran from hold to hike. Against that, the market moved the wrong way for a hawkish document: yields fell across the curve, the dollar fell 0.86%, the VIX fell 6.00%, and the S&P 500, Dow and NYSE Composite all closed higher.

Why it matters:The document was economically stale on arrival, and that is the whole explanation for the non-reaction. Four prints the Committee never saw at the July meeting have already done the repricing: the August 7 payrolls report (-23,000 with combined revisions of -103,000), August 12 CPI (headline 3.4% y/y, core 2.5%), August 13 PPI (final demand flat m/m) and August 14 retail sales (-0.6% m/m) cut September hike odds from roughly two-thirds immediately after the meeting to about a third by August 14. A market that has already moved past a document cannot be moved by it. The risk this creates is asymmetric and under-appreciated: positioning is now built on data that softened after the meeting, while the Committee’s own revealed preference — with zero participants entertaining a cut — sits materially more hawkish than a 31% hike probability implies. Any upside surprise in the September inflation data would force repricing against a market that has stopped listening to the hawks.

What to watch:Chair Warsh’s first Jackson Hole keynote as Chair on Friday, August 28 — nineteen days before the September 16 decision, and unusually high-information because this Fed no longer telegraphs ahead of meetings.

4. Marvell Hands Google a $12.2 Billion Warrant on Roughly 7% of the Company — and Broadcom Pays for It

The core facts:An 8-K filed today disclosed that Marvell has issued Google a warrant to purchase up to 58,970,907 common shares at an exercise price of $206.58 — about $12.18 billion if fully exercised, which would make Alphabet Marvell’s fifth-largest holder at roughly 7% of the company. Vesting is performance-based: approximately 1.36 million shares vest in equal quarterly instalments over the first year, and the remainder splits into 240 tranches running from fiscal Q3 2027 through fiscal 2033, one tranche released per $500 million of eligible custom-product revenue generated through Google. The scope covers AI inference accelerators, storage controllers, network interface controllers, memory interface controllers and near-memory compute attached to the TPU ecosystem. The underlying commercial agreement is dated July 29; today’s disclosure is the trigger. Marvell closed +9.85% at $237.27 on a roughly $194 billion market cap. Broadcom closed -4.61% at $362.48.

Why it matters:Nothing was cancelled — Broadcom’s April long-term agreement with Google covering custom AI chips and rack components through 2031 remains in force. What changed is share of wallet, and the warrant structure is the tell. By tying 240 tranches to $500 million revenue increments, Google has converted a supplier relationship into an equity option whose value it controls directly through its own purchasing decisions, and has done so at an exercise price struck below where Marvell now trades. This is the hyperscalers formalising a second source for custom silicon at the vendor’s expense, and it puts a price on incumbency: Broadcom shed roughly 4.6% on a day when no adverse news about Broadcom itself was published. For portfolio managers holding the custom-ASIC complex, the read-through is that single-hyperscaler concentration is now a valuation liability rather than a moat, and the mechanism by which it gets repriced is dilution granted to the customer.

What to watch:Broadcom’s next quarterly disclosure of custom-AI ASIC revenue and any commentary on 2027-2028 program allocation — the first hard test of whether this is incremental capacity or displacement.

5. The Chip Complex Falls a Second Consecutive 5.5% With All 30 Components Down — This Time on a Day Everything Else Rallied

The core facts:The PHLX Semiconductor Index fell 5.6% with every one of its 30 components declining, one session after a 5.4% fall. Dell closed -6.64% at $437.55, Lam Research -6.33% at $307.17 and Broadcom -4.61% at $362.48. The damage was sufficient to drag the Nasdaq 100 to -0.22% at 29,426.02 on a day when the S&P 500 rose 0.21%, the Dow 0.22%, the NYSE Composite 0.32% and the Russell 2000 0.50%. Technology finished -0.69% as the second-worst S&P sector. No single confirmed catalyst was identified for the complex-wide decline; the Broadcom component is attributable to the Marvell-Google disclosure covered above.

Why it matters:Yesterday’s chip decline came on a risk-off session and was easy to dismiss as beta. Today’s came on a broad advance with falling yields, a weaker dollar and a 6% drop in the VIX — every macro condition that should support long-duration growth equity was present, and the chip complex fell anyway. Breadth removes the last alternative explanation: 30 of 30 down is not stock selection, it is the market marking an entire exposure lower irrespective of individual fundamentals. That combination points to positioning rather than news, and specifically to de-grossing in the most crowded trade of the cycle. The mechanical consequence is visible in the index spread — the Nasdaq 100 negative while the Russell 2000 gained 0.50% is a 0.72-point dispersion that describes a market rotating out of AI capex beneficiaries into everything else. Two sessions do not make a de-rating, but they establish that the chip complex is no longer being bought on macro relief, which is a change of regime from every dip since June.

What to watch:Nvidia’s fiscal Q2 print after the close next Wednesday, August 26 — consensus is roughly $91.99 billion of revenue on $2.09 EPS, and it is the only event this month capable of settling whether this is positioning or fundamentals.

6. Merck and Moderna Post the First Positive Phase 3 for an Individualised Cancer Vaccine — Merck Adds Roughly $44 Billion and Drives the Day’s Best Sector

The core facts:The INTerpath-001 trial of intismeran autogene plus Keytruda in completely resected stage IIB-IV melanoma met both its primary endpoint of recurrence-free survival and its key secondary endpoint of distant metastasis-free survival versus Keytruda alone, across more than 1,100 patients. Both companies confirmed the result in primary releases; they will present at an upcoming international medical meeting and engage regulators on filings. Merck closed +12.60% at $152.20, a new 52-week high and roughly $44 billion of market value added. Healthcare was the day’s best-performing S&P sector at +3.37%, with Eli Lilly +4.46% and Thermo Fisher +4.16% carried along.

Why it matters:This is the first Phase 3 success for an individualised neoantigen therapy — a modality that manufactures a distinct product for each patient — and the platform read-through is larger than the melanoma indication. Merck’s specific problem is well known to anyone holding the name: Keytruda’s principal patents expire toward the end of the decade, and a combination that extends the franchise into adjuvant settings addresses that cliff directly rather than through the usual answer of acquisition. For Moderna the result revalues an mRNA pipeline the market had substantially written down. The sector-level move is the part that matters to allocators: a +3.37% day in Healthcare on a single readout, against a sector already leading the market at +28.61% over twelve months, is a session catalyst reinforcing an existing trend rather than a reversal — and it arrived on a day the chip complex fell 5.6%, which is exactly the rotation defensive-growth buyers have been waiting for.

What to watch:The medical-meeting presentation of the full dataset — hazard ratios and the durability curve are what determine whether this supports a filing in adjuvant melanoma alone or across additional tumour types.

7. Gold, Silver and Platinum Surge Together as the Dollar Breaks — a Rate Trade, Not a Fear Trade

The core facts:Gold rose 3.60% to $4,579.96 an ounce, silver 4.38% to $66.845 and platinum 5.43% to $1,828.00 — the whole precious complex moving in lockstep on the day the dollar index fell 0.86% to 98.80 and the 10-year yield fell 6.8 bps. Copper was effectively unchanged at +0.22%. Basic Materials was the top S&P sector at +3.62%, extending a +10.77% month and a +37.47% twelve months. The move reverses yesterday’s session, when gold fell 1.79% and silver roughly 4%.

Why it matters:Copper is what makes this readable. When precious metals rally 3.6% to 5.4% together while the industrial metal sits flat, the driver is the denominator — real rates and the dollar — not a growth impulse and not a differentiated haven bid. That is a cleaner signal than it appears, because it tells you the metals rally and the equity rally are the same trade expressed twice, both financed by the Treasury buyback announcement rather than by any change in the risk outlook. The uniformity also rules out the interpretation that most concerns allocators: a genuine flight to safety splits the complex, bidding gold hardest and leaving platinum behind, and today did the opposite with platinum leading at +5.43%. The practical implication is that this move unwinds if the dollar stabilises. It is also worth noting how violently the complex is now trading in both directions — a 1.79% fall followed by a 3.60% rise in consecutive sessions is not the behaviour of a quiet hedge allocation, and position sizing should reflect that.

What to watch:The dollar index at 98.80 — a recovery back above 100 would remove the entire mechanical support for this move, while a further break lower extends it regardless of the risk backdrop.

D. MODERATE-IMPACT STORIES -> TOP

8. The UAE Severs All Trade With Iran and Tehran Rejects the Missile Charge — While a Third China-Linked Supertanker U-Turns Inside Hormuz

The core facts:The UAE announced the suspension of all trade, commercial exchange and financial transactions with Iran, after stating that two Iranian ballistic missiles were fired toward it on Tuesday — both falling into the sea, one inside Emirati territorial waters — and that they were aimed at maritime navigation routes in the Strait of Hormuz. Iran’s Foreign Ministry called the accusation baseless today, its first formal response. Separately, ship-tracking published today shows the tanker Hestia transited into the Gulf along the Omani coast early Wednesday, then reversed and sailed out — the third China-linked vessel to U-turn inside the strait after the Sea V and the Amara on Tuesday. Dubai had become Iran’s largest trading partner, ahead of China and Turkiye, supplying roughly a third of Iran’s annual imports. No dollar value for the bilateral trade was published in any source reached. Crude barely moved on the session: WTI +0.25% to $84.27, Brent +0.48% to $91.46.

Why it matters:The tanker U-turns are the observable that matters, because they price transit risk in behaviour rather than in rhetoric. Vessels are entering the strait, evaluating conditions and leaving — that is a commercial judgement being made in real time by Chinese buyers, and it is a cleaner read on the waterway’s usable capacity than any statement from any government. Iran’s formal rejection matters for a narrower reason: it forecloses near-term de-escalation of the Emirati embargo, which removes the most plausible path back to normal Gulf trade flows in the next few weeks. What should give US allocators pause is the disconnect between all of this and the oil price. Crude sat out a session in which a major Gulf state cut off Iran’s largest import channel and a third supertanker refused the transit — which means either the market has fully discounted a prolonged closure, or it is not pricing escalation risk at all. Both readings imply asymmetry: there is far more room for crude to react to bad news here than to good.

What to watch:Daily Hormuz transit counts — a normal run-rate is roughly 73 vessels a day, and recent tracking has recorded single-digit and even single-vessel days. That series, not the headline crude price, is where a genuine supply event would appear first.

9. Bitcoin Jumps 6.25% on the SEC’s Proposed “Regulation Crypto Assets” — the One Move That Did Not Trace to the Treasury

The core facts:Bitcoin rose 6.25% to $68,659, gaining $4,040 on the session and trading as high as roughly $69,000, with ether up about 10%. The catalyst was the SEC’s proposal of “Regulation Crypto Assets,” a tailored securities-offering framework for certain investment contracts involving crypto assets. The proposal creates two exemptions — issuers may raise up to $5 million over four years or up to $75 million annually, subject to disclosure requirements — and, critically, allows certain crypto assets to exit securities classification and the associated reporting obligations once a project fulfils defined managerial commitments. Several crypto executives met the President at the White House on Wednesday afternoon.

Why it matters:The exit ramp from securities classification is the substantive change, and it is the first time the Commission has proposed a mechanism rather than an enforcement posture. Mature networks — bitcoin and ethereum foremost — would gain a defined path out of registration and reporting, which is the precondition institutional allocators have cited for years when explaining why the asset class stays outside mandates. The offering exemptions matter less: $5 million over four years and $75 million annually are small-issuer thresholds, not institutional capital formation. What makes today instructive for cross-asset positioning is that bitcoin’s move was idiosyncratic. Gold rose 3.60% on the dollar, equities rose on the Treasury buyback, and bitcoin rose on the SEC — three rallies, three unrelated catalysts. Anyone holding bitcoin as a macro hedge or a liquidity proxy got no confirmation of that thesis today; the correlation that showed up was to Washington, not to the dollar or to real rates.

What to watch:The comment period and whether the final rule preserves the de-registration pathway — that provision, not the offering exemptions, is what determines whether this changes institutional access.

10. SK Hynix Approves the Largest Share Cancellation in Korean History the Morning After Memory Lost 135 Trillion Won

The core facts:SK hynix’s board approved a 40 trillion won repurchase-and-cancellation programme, roughly $28.6 billion — the largest cancellation by a Korean listed company. It covers up to 24 million shares, about 3.3% of shares outstanding, bought between August 20 and November 19 and then cancelled outright. The board also raised the shareholder-return target to over 50% of cumulative 2025-2027 free cash flow. The announcement came the morning after SK hynix fell 9.75% and Samsung Electronics fell 7.82%, a combined loss of roughly 135 trillion won in market value, with management framing the programme as a response to the market pricing the company below intrinsic value. The US-listed ADR rose about 8% overnight.

Why it matters:This reaches US portfolios through the memory and AI-capex read-through, and the signal is about capital discipline at the supply end of the AI buildout. SK hynix is the dominant supplier of high-bandwidth memory into AI accelerators; a company at that node choosing to cancel 3.3% of its equity rather than deploy the cash into capacity is telling the market it sees better value in its own shares than in incremental fab investment. That is a materially different message from the capex-at-any-price posture that has driven memory equities for two years, and it lands in the same week that the US chip complex has fallen roughly 5.5% on consecutive sessions with all 30 PHLX components down. The cancellation is also permanent in a way buybacks often are not — retired shares cannot be reissued to offset compensation dilution, which makes the per-share arithmetic real rather than cosmetic. For US holders the practical exposure is through the memory read-through into domestic names and through AI-capex sentiment generally, not through the Korean listing.

What to watch:The buyback window opening tomorrow, August 20, and running to November 19 — actual daily repurchase volumes will show whether the 24 million-share ceiling is a commitment or a headline.

11. Nebius Raises $4.50 Billion in Convertibles for AI Data Centres and Falls 9.87% — the Session’s Largest Capital Raise Was Also Its Largest Repudiation

The core facts:Nebius Group launched a $4.50 billion convertible senior notes private offering in two tranches — $2.75 billion due 2030 and $1.75 billion due 2034 — with initial purchasers holding a 13-day option for a further $375 million of the 2030s and $300 million of the 2034s, $675 million in total. The notes are senior unsecured and convertible at Nebius’s election into cash, Class A ordinary shares or a combination. Proceeds fund data-centre construction, AI cloud platform investment, footprint expansion and GPU procurement. The terms were confirmed in an SEC Form 6-K and the company’s own release. The stock closed at $223.90 against a prior close of $248.43, down 9.87%, on volume above 50 million shares, leaving a market capitalisation of roughly $60.87 billion.

Why it matters:A raise equal to roughly 7.4% of market capitalisation, met with a near-10% decline, is the market declining to underwrite the buildout at the offered price — and that is a data point about the neocloud financing channel rather than about one company. This was the only sizeable corporate issuance of the session, arriving in a record month for high-grade supply that had already passed $145.2 billion by Monday. The convertible structure is the informative part: converts are what issuers reach for when straight debt is expensive relative to the equity story they can sell, and the immediate 9.87% response says the equity story is no longer clearing. Set against the same week’s evidence — the PHLX complex down roughly 5.5% twice, and SK hynix choosing share cancellation over capacity — the pattern is consistent: capital is becoming more expensive for AI infrastructure at precisely the point in the cycle when the commitments are largest.

What to watch:Whether the initial purchasers exercise the $675 million upsize option within its 13-day window — declining it would confirm the book was not covered at the level the headline size implies.

12. CrowdStrike Falls 5.30% Into Next Week’s Print on a Day Three Brokers Raised Their Targets

The core facts:CrowdStrike closed -5.30% at $201.63, one of the five largest mega-cap decliners of the session on a roughly $205 billion market capitalisation. No adverse company-specific news was published. In the same session Mizuho reiterated Outperform and raised its target to $240, Truist kept its Buy and raised to $245, and Cantor Fitzgerald maintained Overweight and raised to $250 — every one of those targets above the closing price. The company reports fiscal Q2 2027 after the close on Wednesday, August 26, having guided to annual recurring revenue of $5,792.6-$5,794.6 million and total revenue of $1,436.0-$1,442.0 million.

Why it matters:Sell-side targets going up while the stock goes down 5.30% is a positioning signal, not a fundamental one — holders are de-risking ahead of the print regardless of what the models say, which is the pattern that shows up when the bar has been set by price rather than by guidance. The bar is explicitly high: after a 19% rally since the first-quarter print, one broker has flagged that a beat of more than 3% to second-quarter and full-year net-new ARR consensus may be required to satisfy expectations, having noted the stock’s negative reaction last quarter despite a 2-3% topline beat. That is the definition of a name where good results are not sufficient. The wider read is that today’s software weakness sat alongside a 5.6% fall in the chip complex, which complicates the rotation-into-software thesis that explained yesterday’s tape — on this session, high-multiple growth was sold across both.

What to watch:Net-new ARR on August 26 against the roughly $286 million consensus — the topline is not the number that will move this stock.

13. Eli Lilly Licenses Trans-Amplifying RNA Vaccine Technology From Amplitude on the Same Day mRNA Cancer Data Reset the Sector

The core facts:Eli Lilly signed a strategic research collaboration and licence agreement with Amplitude Therapeutics covering trans-amplifying RNA (taRNA) vaccines for infectious disease. Lilly receives exclusive, target-specific development and commercialisation rights; Amplitude leads taRNA optimisation and selected preclinical work, after which Lilly assumes further preclinical, clinical, manufacturing, regulatory and commercial responsibility. Lilly also holds an option to add up to two additional infectious-disease targets. Financial terms were not disclosed — no upfront, milestone or royalty figure was published — and the initial programmes were not identified. Lilly closed +4.46% at $1,280.34, moving with a Healthcare sector that gained 3.37%.

Why it matters:The sequencing is what gives an undisclosed-terms preclinical deal significance today. taRNA is a self-amplifying architecture that separates the replicase from the antigen-encoding strand, with the practical goal of achieving protective expression at far lower doses than conventional mRNA — the constraint that has governed both reactogenicity and cost of goods across the modality. Lilly taking exclusive rights to that platform on the same session that intismeran autogene delivered the first positive Phase 3 for an individualised neoantigen therapy is not coincidence so much as confirmation: the large-cap pharma bid for RNA platform assets is being re-established after two years in which the market treated the modality as a pandemic artifact. For a company whose valuation rests overwhelmingly on incretins, an option on infectious-disease vaccines is cheap diversification, and the absence of disclosed terms suggests the upfront was small enough not to require it.

What to watch:Whether Lilly exercises the option on either additional target — that decision, rather than any preclinical milestone, is the first observable read on how the platform is performing internally.

E. ECONOMY WATCH -> TOP

Today’s FOMC minutes showed a Fed nine votes from an outright hawkish shift — three regional presidents dissented for a hike, and participants called inflation risk “skewed to the upside” — yet markets shrugged it off, with the S&P 500, Dow, and NYSE Composite all closing higher and the 10-year yield falling. Empire State manufacturing hit its best reading since 2021 and GDPNow held above 4% for Q3, underscoring growth resilience even as September hike odds have slid to roughly 31% on data the Committee never saw. Housing remains the soft spot: NAHB builder confidence ticked up to 35 but stayed below the neutral 40 line for a 16th straight month. Watch whether the growth data holds into September’s payrolls and CPI prints.

F. EARNINGS WATCH -> TOP

YESTERDAY AFTER THE BELL (Markets Reacted Today)

No major earnings yesterday after the bell from companies with >$100B market cap. The largest after-the-bell reporter on Tuesday, August 18 was Keysight Technologies (KEYS) at a $54.59B market cap, followed by Toll Brothers (TOL) at $13.89B. No ADR above $100B reported after Tuesday’s close.

TODAY BEFORE THE BELL (Markets Already Reacted)

TODAY AFTER THE BELL (Markets React Tomorrow)

No major earnings after the bell from companies with >$100B market cap. The largest after-the-bell reporter today was Nordson (NDSN) at a $17.27B market cap. No ADR above $100B reported after today’s close.

WEEK AHEAD PREVIEW:

G. WHAT’S NEXT -> TOP

UPCOMING RELEASES:

KEY QUESTIONS:

H. CHART OF THE DAY -> TOP

Market Intelligence Brief (MIB) Ver. 19.06
For professional investors only. Not investment advice.

© 2026 RecessionALERT.com